News | May 08, 2022
Quality issues force Novartis to suspend production of radioligand therapy medicines
The production suspension impacts commercial and clinical trial supply
The production suspension impacts commercial and clinical trial supply
Survey findings released in advance of World Lupus Day on May 10
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
It affects up to 10 per cent of women of reproductive age around the world
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
TSCS appeals to the Govt. of Telangana to release a G.O for mandatory antenatal test - HbA2 for every pregnant woman to help prevent the birth of Thalassemia Major Children for the well-being of their family & Telangana State
Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours
This is the first major brand refresh of CanSinoBIO since its inception in 2009
All the capex is being met through internal accruals only
Subscribe To Our Newsletter & Stay Updated
